| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1900024 | 重组全人源抗OX40单克隆抗体注射液 | Injection | Biological Products(1) | New Drug Application | 2019-03-19 | 珠海市丽珠单抗生物技术有限公司 | Livzon Mabpharm INC | In Review | 2019-03-18 | view |